Evidence map›Paper›PMID 33842447›Full record

ReviewFrontiers in bioengineering and biotechnology2021

Regenerative Medicine of Epithelia: Lessons From the Past and Future Goals.

Eleonora Maurizi, Davide Adamo, Federica Maria Magrelli, Giulia Galaverni, Eustachio Attico, Alessia Merra, Maria Benedetta Rizzarda Maffezzoni, Lorena Losi, Vincenzo Giuseppe Genna, Virginia Sceberras and 1 more

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Stairways to Advanced Therapies for Epidermolysis Bullosa.Cold Spring Harbor perspectives in biology · 2023
    Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Eleonora MauriziHolostem Terapie Avanzate S.r.l., Modena, Italy.
Davide AdamoInterdepartmental Centre for Regenerative Medicine "Stefano Ferrari", University of Modena and Reggio Emilia, Modena, Italy.
Federica Maria MagrelliHolostem Terapie Avanzate S.r.l., Modena, Italy.
Giulia GalaverniInterdepartmental Centre for Regenerative Medicine "Stefano Ferrari", University of Modena and Reggio Emilia, Modena, Italy.
Eustachio AtticoInterdepartmental Centre for Regenerative Medicine "Stefano Ferrari", University of Modena and Reggio Emilia, Modena, Italy.
Alessia MerraHolostem Terapie Avanzate S.r.l., Modena, Italy.
Maria Benedetta Rizzarda MaffezzoniInterdepartmental Centre for Regenerative Medicine "Stefano Ferrari", University of Modena and Reggio Emilia, Modena, Italy.
Lorena LosiDepartment of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Vincenzo Giuseppe GennaHolostem Terapie Avanzate S.r.l., Modena, Italy.
Virginia SceberrasHolostem Terapie Avanzate S.r.l., Modena, Italy.
Graziella PellegriniHolostem Terapie Avanzate S.r.l., Modena, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article explores examples of successful and unsuccessful regenerative medicine on human epithelia. To evaluate the applications of the first regenerated tissues, the analysis of the past successes and failures addresses some pending issues and lay the groundwork for developing new therapies. Research should still be encouraged to fill the gap between pathologies, clinical applications and what regenerative medicine can attain with current knowledge.

Indexed as

clinical applicationscorneaepidermolysis bullosaepitheliaoral mucosaregenerative medicinesalivary glandtrachea

Identifiers

PMID33842447
PMCPMC8026866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.